| Business Summary | | NetMed,
Inc.
is
engaged
in
the
business
of
acquiring,
developing
and
marketing
medical
and
health-related
technologies.
The
sole
current
business
activity
of
the
Company,
through
its
majority-owned
subsidiary
OxyNet,
Inc.,
is
the
development
and
commercialization
of
products
incorporating
a
new
ceramic-based
technology
for
separation
of
oxygen
from
ambient
air
and
other
gases.
The
first
such
product
targeted
for
commercialization
is
an
oxygen
concentrator
for
use
in
the
home
health
industry. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | NetMed,
Inc.
is
engaged
in
the
acquisition,
development
and
marketing
of
medical
and
health-related
technologies.
The
Company's
revenues
are
currently
derived
principally
from
the
marketing
of
the
PAPNET
Testing
System.
For
the
six
months
ended
6/30/01,
the
Company
reported
no
revenues.
Net
loss
totaled
$169
thousand
vs.
an
income
of
$684
thousand.
Loss
reflects
the
absence
of
$1
million
in
gains
on
the
bankruptcy
of
NSI. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| James Zid, 67 Chairman | -- | S. Trevor Ferger, 46 Pres,
CEO, Director | $100K | Kenneth Leachman, 47 VP-Fin. | -- | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|